The treatment of chronic myelogenous leukemia by interferon and cytosine-arabinoside: rational and design of the French trials. French CML Study Group

MeSH terms

• Adult
• Aged
• Antineoplastic Agents / administration & dosage*
• Antineoplastic Agents / adverse effects
• Combined Modality Therapy
• Cytarabine / administration & dosage*
• Drug Tolerance
• France
• Humans
• Hydroxyurea / administration & dosage
• Interferon alpha-2
• Interferon-alpha / administration & dosage*
• Interferon-alpha / adverse effects
• Leukemia, Myeloid, Chronic-Phase / drug therapy*
• Leukemia, Myeloid, Chronic-Phase / therapy*
• Middle Aged
• Randomized Controlled Trials as Topic / methods*
• Recombinant Proteins